Journey Medical (DERM) Current Assets (2020 - 2026)

Journey Medical (DERM) has reported Current Assets for 7 consecutive years, with $72.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Assets rose 41.96% year-over-year to $72.8 million; the trailing twelve-month figure through Jun 2026 stood at $72.8 million (up 41.96% YoY), and the FY2025 full-year result was $66.9 million, up 38.8% from the prior year.
• Current Assets improved to $72.8 million in Q2 2026 per DERM's latest filing, from $65.0 million in the prior quarter.
• Across five years, Current Assets topped out at $90.3 million in Q1 2022 and bottomed at $44.7 million in Q3 2023.
• Historically, Current Assets has averaged $60.8 million across 5 years, with a median of $56.4 million in 2023.
• The sharpest annual moves came in 2023 and 2026: Current Assets sank 43.86% in 2023, then jumped 41.96% in 2026.
• Over 5 years, Current Assets stood at $77.7 million in 2022, then retreated by 27.32% to $56.5 million in 2023, then declined by 14.66% to $48.2 million in 2024, then surged by 38.8% to $66.9 million in 2025, then increased by 8.83% to $72.8 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $72.8 million, $65.0 million, and $66.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.